Goal 3: Advance Translational Research

Should Allogeneic stem cell transplantation be considered as an upfront treatment in high risk double hit DLBCL?

Double-hit lymphomas (DHL’s) are high-grade B-cell lymphomas characterized by chromosomal rearrangements of MYC gene with BCL2 and less commonly, BCL6.Large analysis of patients with de novo DLBCL have shown that conventional chemotherapy does not improve the survival of DHL Aggressive upfront chemotherapy followed by autologous stem cell transplantation (ASCT) has become a standard treatment in eligible patients. Retrospective analysis has shown that intensive chemotherapies such as dose-adjusted R-EPOCH, HyperCVAD/MTX+AraC or CODOX-M/IVAC produce improved response rates. ASCT did not improve OS.

Tags (Keywords associated with the idea)


2 net votes
3 up votes
1 down votes
Idea No. 1122